Generic Biosimilar Medicines Association

Making Medicines Affordable

Home
About GBMA
Advocacy
Generics
Biosimilars
- GBMA Position on Biosimilars
- Key Figures on Biosimilars
Topics
News
- News 2019
- News 2018
- News 2017
- News 2016
- News 2015
- News 2014
GBMA Education

You are here: Home / Biosimilars / GBMA Position on Biosimilars / Key Figures on Biosimilars

Key Figures on Biosimilars

Budget 2019-20 – Budget spending on health and new medicines a welcome investment in the health of Australians

April 3, 2019

2 April 2019 Canberra, ACT The Generic and Biosimilar Medicines Association (GBMA), peak body for generic and biosimilar medicines, … More...

Health Minister Announces Details of 2019 Biosimilar Week

March 8, 2019

To focus on the role of biosimilar medicines in supporting a sustainable healthcare system … More...

Peak body for Generic and Biosimilar medicines welcomes legislation to inform patients about medicine shortages

September 11, 2018

11 September 2018 Canberra, ACT New laws, aimed at better informing patients about … More…

© 2019 Generic Medicines Industry Association Pty Ltd | Site Map | Contact Us